| # | Drug | Count |
|---|---|---|
| 0 | ALIROCUMAB | 608 |
| 1 | ALBUTEROL SULFATE | 553 |
| 2 | FLUTICASONE PROPIONATE | 340 |
| 3 | AZELASTINE | 339 |
| 4 | AZELASTINE HYDROCHLORIDE | 317 |
| 5 | FLUTICASONE PROPIONATE NASAL | 270 |
| 6 | VARENICLINE | 252 |
| 7 | IPRATROPIUM BROMIDE | 207 |
| 8 | PERFLUOROHEXYLOCTANE | 201 |
| 9 | CYCLOSPORINE | 178 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PERFLUOROHEXYLOCTANE | 201 | 0.0865 |
| 1 | ALIROCUMAB | 608 | 0.0236 |
| 2 | OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE | 46 | 0.0226 |
| 3 | IPRATROPIUM BROMIDE AND ALBUTEROL | 58 | 0.0210 |
| 4 | AZELASTINE | 339 | 0.0182 |
| 5 | CALCITONIN SALMON | 42 | 0.0134 |
| 6 | LOTILANER OPHTHALMIC SOLUTION | 43 | 0.0110 |
| 7 | TIOTROPIUM BROMIDE AND OLODATEROL | 56 | 0.0109 |
| 8 | BRIMONIDINE TARTRATE, TIMOLOL MALEATE | 65 | 0.0098 |
| 9 | OLOPATADINE HYDROCHLORIDE | 53 | 0.0091 |
| # | Drug class | Count |
|---|---|---|
| 0 | PCSK9 Inhibitor [EPC] | 612 |
| 1 | Corticosteroid [EPC] | 344 |
| 2 | Prostaglandin Analog [EPC] | 262 |
| 3 | Calcineurin Inhibitor Immunosuppressant [EPC] | 220 |
| 4 | Semifluorinated Alkane [EPC] | 201 |
| 5 | Androgen [EPC] | 155 |
| 6 | Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] | 130 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 75 |
| 8 | Sulfone [EPC] | 59 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 52 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Semifluorinated Alkane [EPC] | 201 | 0.0865 |
| 1 | PCSK9 Inhibitor [EPC] | 612 | 0.0238 |
| 2 | Oxaborole Antifungal [EPC] | 1 | 0.0143 |
| 3 | Calcitonin [EPC] | 42 | 0.0134 |
| 4 | Ectoparasiticide [EPC] | 43 | 0.0110 |
| 5 | Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] | 130 | 0.0079 |
| 6 | Androgen [EPC] | 155 | 0.0057 |
| 7 | Sulfone [EPC] | 59 | 0.0054 |
| 8 | Polyene Antimicrobial [EPC] | 2 | 0.0049 |
| 9 | Interleukin-5 Antagonist [EPC] | 3 | 0.0044 |